AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 37543161 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 186
Study 37543256 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 3521
Study 37543256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3521
Study 37543256 — intervention group
Group type: EXPERIMENTAL
Intervention: SGLT2i
Number of subjects: 3521
Study 37543256 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 3521
Study 37543437 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen (HFNO)
Number of subjects: 83
Study 37543437 — intervention group
Group type: COMPARATOR
Intervention: Conventional oxygen treatment with a Venturi mask
Number of subjects: 83
Study 37543464 — intervention group
Group type: EXPERIMENTAL
Intervention: eTURB
Number of subjects: 384
Study 37543512 — intervention group
Group type: EXPERIMENTAL
Intervention: exMPC (exercise-aware model predictive control)
Number of subjects: 27
Study 37543512 — intervention group
Group type: EXPERIMENTAL
Intervention: exAPD (exercise-aware adaptive proportional derivative)
Number of subjects: 27
Study 37543521 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 63
Study 37543575 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent bolus paravertebral block (ropivacaine 0.5% loading, 0.2% infusion)
Number of subjects: 80
Study 37543587 — intervention group
Group type: EXPERIMENTAL
Intervention: Anlotinib plus icotinib
Number of subjects: 60
Study 37543590 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive stimulation guided by PREVEDEL software for five continuous days
Number of subjects: 0
Study 37543590 — intervention group
Group type: COMPARATOR
Intervention: Tablet without the PREVEDEL software (Control group)
Number of subjects: 0
Study 37543602 — intervention group
Group type: EXPERIMENTAL
Intervention: Tear biomarkers (Aβ38, Aβ40, Aβ42, t-tau, p-tau) measured using multiplex immunoassays
Number of subjects: 200
Study 37543602 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI scan, neuropsychological tests, ophthalmic examination
Number of subjects: 200
Study 37543602 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral spinal fluid collection and amyloid PET scan (subset of participants)
Number of subjects: 200
Study 37543602 — intervention group
Group type: EXPERIMENTAL
Intervention: Macular pigment optical density measurement and retinal imaging
Number of subjects: 200
Study 37543639 — intervention group
Group type: EXPERIMENTAL
Intervention: Grip strength (GS) measured using the Martin Vigorimeter, with cut-points derived for dominant hand (DH) and non-dominant hand (NDH) based on 4 definitions of weakness.
Number of subjects: 976
Study 37543755 — intervention group
Group type: EXPERIMENTAL
Intervention: EVL plus propranolol till eradication of esophageal varices (EEV)
Number of subjects: 212
Study 37543755 — intervention group
Group type: COMPARATOR
Intervention: EVL plus continuing propranolol
Number of subjects: 212
Study 37543959 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic Macular Edema (DME)
Number of subjects: 82
Study 37543959 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 82
Study 37544143 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple antithrombotic treatment consisting of subcutaneous enoxaparin, VKA, and discontinued aspirin
Number of subjects: 308
Study 37544239 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossword puzzles as an active learning method for three lesson hours following the standard lecture technique.
Number of subjects: 72
Study 37544239 — intervention group
Group type: COMPARATOR
Intervention: Standard lecture technique as a traditional method.
Number of subjects: 72
Study 37544326 — intervention group
Group type: EXPERIMENTAL
Intervention: cAd3-EBO S vaccine at 1 × 10^11 viral particles
Number of subjects: 40
Study 37544326 — intervention group
Group type: EXPERIMENTAL
Intervention: cAd3-EBO S vaccine at 1 × 10^10 viral particles
Number of subjects: 40
Study 37544410 — intervention group
Group type: EXPERIMENTAL
Intervention: Liso-cel
Number of subjects: 0
Study 37544410 — intervention group
Group type: COMPARATOR
Intervention: ASCT
Number of subjects: 0
Study 37544492 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine chemistry-guided diuretic strategy
Number of subjects: 450
Study 37544492 — intervention group
Group type: COMPARATOR
Intervention: Usual care strategy
Number of subjects: 450
Study 37544691 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology addiction training for 10 weeks
Number of subjects: 82
Study 37544691 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 82
Study 37545129 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovenous laser ablation (EVLA) using the ELVeS® Radial® 2ring slim fiber
Number of subjects: 150
Study 37545290 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of CYFRA 21-1 and CA 125 biomarkers
Number of subjects: 480
Study 37545290 — intervention group
Group type: COMPARATOR
Intervention: Low-risk SD patients
Number of subjects: 480
Study 37545290 — intervention group
Group type: COMPARATOR
Intervention: High-risk SD patients
Number of subjects: 480
Study 37545298 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent low-carbohydrate diet (ILCD) - carbohydrate intake ≤ 50 g/d on seven nonconsecutive days
Number of subjects: 34
Study 37545298 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent low-carbohydrate diet (ILCD)
Number of subjects: 34
Study 37545298 — intervention group
Group type: COMPARATOR
Intervention: Calorie restriction (ICR) - 500-600 kcal/d for two consecutive days per week
Number of subjects: 34
Study 37545359 — intervention group
Group type: EXPERIMENTAL
Intervention: teleCBIT (8 sessions guided by a manualized protocol)
Number of subjects: 0
Study 37545359 — intervention group
Group type: EXPERIMENTAL
Intervention: teleCBIT
Number of subjects: 0
Study 37545387 — intervention group
Group type: EXPERIMENTAL
Intervention: DTG + TAF/FTC
Number of subjects: 31
Study 37545387 — intervention group
Group type: COMPARATOR
Intervention: Dolutegravir/lamivudine
Number of subjects: 31
Study 37545387 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 31
Study 37545392 — intervention group
Group type: EXPERIMENTAL
Intervention: CAP-100 (anti-CCR7 antibody)
Number of subjects: 0
Study 37545392 — intervention group
Group type: COMPARATOR
Intervention: Venetoclax
Number of subjects: 0
Study 37545406 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacosamide (LCM) up to 12 mg/kg/day or 600 mg/day
Number of subjects: 55
Study 37545406 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacosamide (LCM)
Number of subjects: 55
Study 37545466 — intervention group
Group type: EXPERIMENTAL
Intervention: Water First intervention (classroom lessons, water stations, schoolwide water promotion over 1 school year)
Number of subjects: 1249
Study 37545466 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1249
Study 37545577 — intervention group
Group type: EXPERIMENTAL
Intervention: Double burden of malnutrition (DBM)
Number of subjects: 742
Study 37545577 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 742
Study 37545577 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex
Number of subjects: 742
Study 37545577 — intervention group
Group type: EXPERIMENTAL
Intervention: School type
Number of subjects: 742
Study 37545577 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimum dietary diversity score
Number of subjects: 742
Study 37545577 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency of meals
Number of subjects: 742
Study 37545577 — intervention group
Group type: EXPERIMENTAL
Intervention: Home gardening practice
Number of subjects: 742
Study 37545577 — intervention group
Group type: EXPERIMENTAL
Intervention: History of illness
Number of subjects: 742
Study 37545577 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of nutrition
Number of subjects: 742
Study 37545580 — intervention group
Group type: EXPERIMENTAL
Intervention: Early oral feeding (EOF)
Number of subjects: 898
Study 37545580 — intervention group
Group type: COMPARATOR
Intervention: Delayed oral feeding (DOF)
Number of subjects: 898
Study 37545595 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-Cog screening for preoperative cognitive impairment (scores ≤ 3)
Number of subjects: 153
Study 37545595 — intervention group
Group type: COMPARATOR
Intervention: Normal cognitive function (Mini-Cog scores > 3)
Number of subjects: 153
Study 37545629 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex interactive multimodal intervention including advanced education via mobile connection, participation in a web-based social network, tailored feedback, and support of a nurse coach.
Number of subjects: 0
Study 37545629 — intervention group
Group type: COMPARATOR
Intervention: Self-guided stress management (Control group).
Number of subjects: 0
Study 37545735 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS targeting the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 90
Study 37545735 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS targeting the left angular gyrus (AG)
Number of subjects: 90
Study 37545735 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized rTMS based on RCT results
Number of subjects: 90
Study 37545735 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 90
Study 37545735 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention in longitudinal personalized trial
Number of subjects: 90
Study 37545861 — intervention group
Group type: EXPERIMENTAL
Intervention: GV1001 1.12 mg
Number of subjects: 0
Study 37545861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 37546286 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellular scales in Log2Lose trial
Number of subjects: 0
Study 37546286 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR weights in MAINTAIN trial
Number of subjects: 0
Study 37546286 — intervention group
Group type: COMPARATOR
Intervention: Pragmatic methods in both studies
Number of subjects: 0
Study 37546352 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerviron
Number of subjects: 0
Study 37546740 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 μM quercetin for three days
Number of subjects: 0
Study 37546740 — intervention group
Group type: COMPARATOR
Intervention: DMSO
Number of subjects: 0
Study 37546740 — intervention group
Group type: EXPERIMENTAL
Intervention: Quercetin for 6 months in COPD patients
Number of subjects: 0
Study 37546740 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months in COPD patients
Number of subjects: 0
Study 37546787 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume control
Number of subjects: 0
Study 37546787 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure control
Number of subjects: 0
Study 37546787 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive pressure control
Number of subjects: 0
Study 37546872 — intervention group
Group type: EXPERIMENTAL
Intervention: VR neuroscience-based therapy (VRNT)
Number of subjects: 31
Study 37546872 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 31
Study 37547219 — intervention group
Group type: EXPERIMENTAL
Intervention: CALMA m-health app
Number of subjects: 0
Study 37547219 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 37547446 — intervention group
Group type: EXPERIMENTAL
Intervention: High symptom group (FACT-ES score tertile)
Number of subjects: 977
Study 37547446 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot flashes
Number of subjects: 977
Study 37547446 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast sensitivity
Number of subjects: 977
Study 37547448 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretreatment tumors
Number of subjects: 96
Study 37547448 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttreatment residual tumors in the breast and lymph nodes after neoadjuvant chemotherapy
Number of subjects: 96
Study 37547664 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotoxic childhood therapy
Number of subjects: 12
Study 37547785 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 37547856 — intervention group
Group type: EXPERIMENTAL
Intervention: LinkUP (single-session motivational interviewing intervention)
Number of subjects: 149
Study 37547856 — intervention group
Group type: COMPARATOR
Intervention: Control (attention-matched didactic control condition)
Number of subjects: 149
Study 37547978 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous perampanel (IV)
Number of subjects: 21
Study 37548010 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis for acute stroke in the prehospital setting
Number of subjects: 0
Study 37548010 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced prehospital diagnostics for large vessel occlusion and intracranial hemorrhage
Number of subjects: 0
Study 37548009 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor-aspirin
Number of subjects: 6336
Study 37548009 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel-aspirin
Number of subjects: 6336
Study 37548022 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic repair
Number of subjects: 65
Study 37548022 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic debridement
Number of subjects: 65
Study 37548085 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 724
Study 37548158 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgically closed VSDs
Number of subjects: 30
Study 37548158 — intervention group
Group type: EXPERIMENTAL
Intervention: Unrepaired VSDs
Number of subjects: 30
Study 37548158 — intervention group
Group type: COMPARATOR
Intervention: General population
Number of subjects: 30
Study 37548390 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral blood complete remission (PB-CR)
Number of subjects: 1441
Study 37548390 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete remission (CR) with additional PB-CR
Number of subjects: 1441
Study 37548510 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided infraclavicular cannulation of the axillary artery (A group)
Number of subjects: 110
Study 37548510 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided cannulation of the common femoral artery (F group)
Number of subjects: 110
Study 37548555 — intervention group
Group type: EXPERIMENTAL
Intervention: UGN-102 once weekly for 6 weeks
Number of subjects: 282
Study 37548555 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of bladder tumor monotherapy
Number of subjects: 282
Study 37548555 — intervention group
Group type: EXPERIMENTAL
Intervention: UGN-102 ± transurethral resection of bladder tumor
Number of subjects: 282
Study 37548555 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of bladder tumor
Number of subjects: 282
Study 37548623 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pump (IABP)
Number of subjects: 5343
Study 37548623 — intervention group
Group type: COMPARATOR
Intervention: Control (no IABP)
Number of subjects: 5343
Study 37548804 — intervention group
Group type: EXPERIMENTAL
Intervention: EC aerosol with nicotine
Number of subjects: 22
Study 37548804 — intervention group
Group type: COMPARATOR
Intervention: EC aerosol without nicotine
Number of subjects: 22
Study 37548831 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab (n=66)
Number of subjects: 143
Study 37548831 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (n=77)
Number of subjects: 143
Study 37548850 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal bevacizumab (IT BEV)
Number of subjects: 1
Study 37548850 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous bevacizumab (IA BEV)
Number of subjects: 1
Study 37548968 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted hypothermia at 33 °C
Number of subjects: 1861
Study 37548968 — intervention group
Group type: COMPARATOR
Intervention: Targeted normothermia (37.8 °C or higher)
Number of subjects: 1861
Study 37548980 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 yes or no questions for estimating pack-year eligibility
Number of subjects: 0
Study 37548984 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular BP cuff
Number of subjects: 195
Study 37548984 — intervention group
Group type: COMPARATOR
Intervention: Too-small BP cuff
Number of subjects: 195
Study 37548984 — intervention group
Group type: COMPARATOR
Intervention: Too-large BP cuff
Number of subjects: 195
Study 37548984 — intervention group
Group type: COMPARATOR
Intervention: Appropriate BP cuff
Number of subjects: 195
Study 37548983 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital plain language recommendation (PLR) format
Number of subjects: 268
Study 37548983 — intervention group
Group type: COMPARATOR
Intervention: Standard language version (SLV)
Number of subjects: 268
Study 37549004 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement in a mobile peer support community using an app for tracking steps (n=93)
Number of subjects: 202
Study 37549004 — intervention group
Group type: COMPARATOR
Intervention: Using the app for step tracking only (n=93)
Number of subjects: 202
Study 37549139 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal high-definition transcranial direct current stimulation (1mA for 20 min)
Number of subjects: 105
Study 37549139 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal high-definition transcranial direct current stimulation (1mA for 20 min)
Number of subjects: 105
Study 37549139 — intervention group
Group type: COMPARATOR
Intervention: Sham high-definition transcranial direct current stimulation (1mA for 20 min)
Number of subjects: 105
Study 37549192 — intervention group
Group type: EXPERIMENTAL
Intervention: Bnt162b2 vaccine (3 doses)
Number of subjects: 26
Study 37549351 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with active acromegaly
Number of subjects: 26
Study 37549351 — intervention group
Group type: EXPERIMENTAL
Intervention: Acromegaly treatment
Number of subjects: 26
Study 37549370 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee hyperextension group (study group)
Number of subjects: 40
Study 37549370 — intervention group
Group type: COMPARATOR
Intervention: Control group (no knee hyperextension)
Number of subjects: 40
Study 37549385 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Needs Case Management
Number of subjects: 0
Study 37549385 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 37549428 — intervention group
Group type: EXPERIMENTAL
Intervention: ADS Plus (intervention)
Number of subjects: 203
Study 37549428 — intervention group
Group type: COMPARATOR
Intervention: ADS (control)
Number of subjects: 203
Study 37549442 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal magnetic resonance imaging (MRI) studies of the placenta at 14-16 weeks gestational age (GA)
Number of subjects: 199
Study 37549442 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal magnetic resonance imaging (MRI) studies of the placenta at 19-24 weeks gestational age (GA)
Number of subjects: 199
Study 37549442 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI indices showing decreased placental volume, perfusion, and oxygenation
Number of subjects: 199
Study 37549532 — intervention group
Group type: EXPERIMENTAL
Intervention: Crizotinib
Number of subjects: 24
Study 37549598 — intervention group
Group type: EXPERIMENTAL
Intervention: LCPUFA-ω3 supplementation (225 mg DHA, 45 mg EPA, administered at 0.100 g/kg of body weight/day for 3 months)
Number of subjects: 72
Study 37549598 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (500 mg sunflower oil)
Number of subjects: 72
Study 37549675 — intervention group
Group type: EXPERIMENTAL
Intervention: Perfluorocarbons (PFCs) used as oxygen carriers and red blood cell substitutes
Number of subjects: 0
Study 37549675 — intervention group
Group type: EXPERIMENTAL
Intervention: PFCs as adjunct in cancer therapies
Number of subjects: 0
Study 37549675 — intervention group
Group type: EXPERIMENTAL
Intervention: PFCs for donor organ perfusion
Number of subjects: 0
Study 37549675 — intervention group
Group type: EXPERIMENTAL
Intervention: PFCs as airway mechanotransducers
Number of subjects: 0
Study 37549680 — intervention group
Group type: EXPERIMENTAL
Intervention: CoronaVac (third dose)
Number of subjects: 451
Study 37549680 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 (third dose)
Number of subjects: 451
Study 37549724 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside family planning counseling and offer of contraception (oral contraceptive pills, etonogestrel implant, or medroxyprogesterone injection)
Number of subjects: 76
Study 37549724 — intervention group
Group type: COMPARATOR
Intervention: Flyer recommending discussion with outpatient physician about contraception
Number of subjects: 76
Study 37549724 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 76
Study 37549753 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-CDS
Number of subjects: 144
Study 37549753 — intervention group
Group type: COMPARATOR
Intervention: ERCP-M
Number of subjects: 144
Study 37549836 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovarian tissue cryopreservation via laparoscopic unilateral ovariectomy
Number of subjects: 106
Study 37549836 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovarian tissue cryopreservation
Number of subjects: 106
Study 37549923 — intervention group
Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine
Number of subjects: 0
Study 37549933 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.5 mg/5 mL in Mucolox™
Number of subjects: 29
Study 37549933 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 0.5 mg/5 mL solution (standard arm)
Number of subjects: 29
Study 37549979 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated fibrosis score calculation and electronic reminder messages
Number of subjects: 1061
Study 37549979 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1061
Study 37550019 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose oral secnidazole 2 g
Number of subjects: 131
Study 37550019 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 37550025 — intervention group
Group type: EXPERIMENTAL
Intervention: High subjective cognitive impairment group
Number of subjects: 200
Study 37550025 — intervention group
Group type: COMPARATOR
Intervention: Low subjective cognitive impairment group
Number of subjects: 200